Recruiting Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders NCT07221851 Conditions Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +32 more Locations Ascendis Pharma Investigational Site — Palo Alto, California, United States Ascendis Pharma Investigational Site — Sacramento, California, United States Ascendis Pharma Investigational Site — Aurora, Colorado, United States Ascendis Pharma Investigational Site — Centennial, Colorado, United States View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details
